Capital Counsel’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,727
| Closed | -$247K | – | 60 |
|
|
2025
Q1 | $247K | Sell |
8,727
-13
| -0.1% | -$369 | 0.01% | 47 |
|
|
2024
Q4 | $363K | Sell |
8,740
-330
| -4% | -$13.7K | 0.02% | 43 |
|
|
2024
Q3 | $606K | Hold |
9,070
| – | – | 0.03% | 36 |
|
|
2024
Q2 | $1.08M | Sell |
9,070
-900
| -9% | -$107K | 0.05% | 30 |
|
|
2024
Q1 | $1.06M | Sell |
9,970
-431
| -4% | -$45.9K | 0.05% | 31 |
|
|
2023
Q4 | $1.03M | Sell |
10,401
-170
| -2% | -$16.9K | 0.05% | 32 |
|
|
2023
Q3 | $1.09M | Buy |
10,571
+2,353
| +29% | +$243K | 0.06% | 29 |
|
|
2023
Q2 | $998K | Hold |
8,218
| – | – | 0.06% | 30 |
|
|
2023
Q1 | $1.26M | Buy |
8,218
+450
| +6% | +$69.1K | 0.07% | 29 |
|
|
2022
Q4 | $1.4M | Buy |
7,768
+21
| +0.3% | +$3.77K | 0.09% | 26 |
|
|
2022
Q3 | $916K | Buy |
7,747
+30
| +0.4% | +$3.55K | 0.06% | 30 |
|
|
2022
Q2 | $1.1M | Buy |
7,717
+24
| +0.3% | +$3.43K | 0.07% | 29 |
|
|
2022
Q1 | $1.33M | Sell |
7,693
-6
| -0.1% | -$1.03K | 0.06% | 28 |
|
|
2021
Q4 | $1.96M | Sell |
7,699
-91
| -1% | -$23.1K | 0.08% | 24 |
|
|
2021
Q3 | $3M | Sell |
7,790
-50
| -0.6% | -$19.2K | 0.15% | 21 |
|
|
2021
Q2 | $1.84M | Sell |
7,840
-180
| -2% | -$42.3K | 0.09% | 26 |
|
|
2021
Q1 | $1.05M | Buy |
+8,020
| New | +$1.05M | 0.06% | 32 |
|